Antihistamine Drugs Market Research Report - Global Forecast Till 2027

Antihistamine Drugs Market share, growth and trends analysis By Type (Sedating, Non-Sedating), By Route of Administration (Oral Route, Parenteral Route, Rectal Route), By Indication (Allergy, Urticaria, Dermatitis, and others), End User (Hospitals, Clinics, Pharmaceutical Companies and others) - Global Forecast Till 2027

ID: MRFR/Pharma/2913-HCR | February 2021 | Region: Global | 206 pages

Please note that the assessment period of report has been updated from 2023 to 2027. Cordially fill the sample form for updated data.

Market Synopsis of the Global Antihistamine drugs Market

Antihistamines are drugs mainly used for treating allergies. They are also used to treat motion sickness, insomnia and anxiety. They work by acting against a chemical called histamine which leads to many allergic symptoms. Antihistamines may cause side effects such as dizziness, dry mouth, nervousness, irritability, blurry vision and decreased appetite.

The global antihistamine drugs market is expected to grow at a CAGR of 9.8% during the forecast period and is estimated to reach USD 280 million by 2023.

 FIGURE 1 Global Antihistamine drugs Market by Region, 2016 (%)
Antihistamine Drugs Market

Key Players in the Global Antihistamine drugs Market        
Some of the key players in this market are Johnson & Johnson Consumer Inc. (U.S.), Sanofi (France), Bayer AG (Germany), Pfizer (U.S.), CVS pharmacy (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), and Prestige Brands Holdings, Inc. (U.S.)

The global antihistamine drugs market is segmented on the basis of types which includes sedating and non-sedating antihistamines. Sedating antihistamines are further sub-segmented into brompheniramine, chlorpheniramine, diphenhydramine, doxylamine, carbinoxamine and others. Non-sedating antihistamines are further sub-segmented into fexofenadine, loratadine, loratadine odt, and others.

On the basis of route of administration, the market is segmented into oral route, parenteral route and rectal route. Parenteral route segmented is further sub-segmented into intramuscular, subcutaneous and intravenous route.

On the basis of indication, the market is segmented into allergy, urticaria, dermatitis, and others. And on the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies and others.
FIGURE 2 Research Methodology

Global Antihistamine Drugs Market

Regional Analysis of the Global Antihistamine drugs Market                 

The American region accounts for the largest share of the global market due to rising prevalence of allergy rhinitis and rising demand for diagnosis and treatment of allergic disease. According to the American College of Allergy Asthma and Immunology, allergic asthma, food allergy, and eczema are the most common types of allergies found in the U.S.

Europe is the second largest market that holds a noticeable share of the global antihistamine drugs market. According to the European Academy of Allergy and Clinical Immunology (EAACI), more than 50% of all Europeans will suffer from allergy in coming years.

In Asia Pacific, increase in the demand for drugs for the treatment of allergies and skin diseases drive the market growth. There has been a rise in the number of dermatology clinics across Asia Pacific from past few years. High rates of allergic rhinitis and increasing awareness regarding treatments available for allergy is poised to drive the growth of this market in Asia Pacific.

The Middle East & Africa, the market shows steady but positive growth due to the rising prevalence of nasal allergies.

Intended Audience:

  • Antihistamine drug manufacturers

  • Antihistamine drug suppliers

  • Medical research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Frequently Asked Questions (FAQ) :

The Antihistamine Drug Market valuation would be USD 280 million.

The players are Sanofi (France), Johnson & Johnson Consumer Inc. (U.S.), Pfizer (U.S.), CVS pharmacy (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), Bayer AG (Germany), and Prestige Brands Holdings, Inc. (U.S.).

The types are sedating and non-sedating antihistamines.

The types are allergy, urticaria, dermatitis, and others.

Brief TOC

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain

5.3 Investment Feasibility Analysis

5.4 Price Factor Analysis

6 Global Antihistamine drugs Market, by Type

6.1 Introduction

6.2 Sedating Antihistamine Drugs

6.2.1 Brompheniramine

6.2.2 Chlorpheniramine

6.2.3 Diphenhydramine

6.2.4 Doxylamine

6.2.5 Carbinoxamine

6.2.6 Others

6.3 Non-Sedating Antihistamine Drugs

6.3.1 Fexofenadine

6.3.2 Loratadine

6.3.3 Loratadine ODT

6.3.4 Others

7 Global Antihistamine Drugs Market, By Route of Administration

7.1 Introduction

7.2 Oral Route

7.3 Parenteral Route

7.3.1 Intramuscular

7.3.2 Subcutaneous

7.3.3 Intravenous Route

7.4 Rectal Route

8 Global Antihistamine Drugs Market, by Indication

8.1 Introduction

8.2 Allergy

8.3 Urticaria

8.4 Dermatitis

8.5 Others

9 Global Antihistamine Drugs Market by End User

9.1 Introduction

9.2 Hospitals

9.3 Clinics

9.4 Pharmaceutical Companies

9.5 Others

10 Global Antihistamine Drugs Market by Region

10.1 Introduction

10.2 Americas

10.2.1 North America U.S. Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe Germany France UK Italy Spain Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Republic of Korea

10.4.5 Australia

10.4.6 Rest of Asia Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Johnson & Johnson Consumer Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Sanofi

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Bayer AG

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Pfizer

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Merck Sharp & Dohme Corp.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.6 Prestige Brands Holdings, Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 CVS Pharmacy

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical Industry

14 Appendix